BLOOMIN' BRANDS INC (BLMN) Fundamental Analysis & Valuation

NASDAQ:BLMNUS0942351083

Current stock price

6.01 USD
-0.02 (-0.33%)
At close:
6.01 USD
0 (0%)
After Hours:

This BLMN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BLMN Profitability Analysis

1.1 Basic Checks

  • In the past year BLMN was profitable.
  • In the past year BLMN had a positive cash flow from operations.
  • Of the past 5 years BLMN 4 years were profitable.
  • In the past 5 years BLMN always reported a positive cash flow from operatings.
BLMN Yearly Net Income VS EBIT VS OCF VS FCFBLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

1.2 Ratios

  • BLMN's Return On Assets of 0.26% is on the low side compared to the rest of the industry. BLMN is outperformed by 61.90% of its industry peers.
  • BLMN has a Return On Equity (2.47%) which is in line with its industry peers.
  • The Return On Invested Capital of BLMN (3.81%) is worse than 60.32% of its industry peers.
  • BLMN had an Average Return On Invested Capital over the past 3 years of 6.97%. This is below the industry average of 10.55%.
Industry RankSector Rank
ROA 0.26%
ROE 2.47%
ROIC 3.81%
ROA(3y)1.23%
ROA(5y)2.66%
ROE(3y)-10.51%
ROE(5y)21.12%
ROIC(3y)6.97%
ROIC(5y)9.18%
BLMN Yearly ROA, ROE, ROICBLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

  • The Profit Margin of BLMN (0.21%) is worse than 61.11% of its industry peers.
  • In the last couple of years the Profit Margin of BLMN has declined.
  • BLMN has a worse Operating Margin (2.79%) than 72.22% of its industry peers.
  • BLMN's Operating Margin has declined in the last couple of years.
  • BLMN has a better Gross Margin (70.24%) than 85.71% of its industry peers.
  • BLMN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.79%
PM (TTM) 0.21%
GM 70.24%
OM growth 3Y-28.44%
OM growth 5YN/A
PM growth 3Y-55.15%
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y0.25%
BLMN Yearly Profit, Operating, Gross MarginsBLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

2

2. BLMN Health Analysis

2.1 Basic Checks

  • BLMN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, BLMN has more shares outstanding
  • The number of shares outstanding for BLMN has been reduced compared to 5 years ago.
  • The debt/assets ratio for BLMN has been reduced compared to a year ago.
BLMN Yearly Shares OutstandingBLMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
BLMN Yearly Total Debt VS Total AssetsBLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 0.84, we must say that BLMN is in the distress zone and has some risk of bankruptcy.
  • BLMN has a worse Altman-Z score (0.84) than 69.05% of its industry peers.
  • BLMN has a debt to FCF ratio of 8.25. This is a slightly negative value and a sign of low solvency as BLMN would need 8.25 years to pay back of all of its debts.
  • BLMN's Debt to FCF ratio of 8.25 is fine compared to the rest of the industry. BLMN outperforms 62.70% of its industry peers.
  • BLMN has a Debt/Equity ratio of 2.38. This is a high value indicating a heavy dependency on external financing.
  • BLMN's Debt to Equity ratio of 2.38 is in line compared to the rest of the industry. BLMN outperforms 44.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.38
Debt/FCF 8.25
Altman-Z 0.84
ROIC/WACC0.49
WACC7.77%
BLMN Yearly LT Debt VS Equity VS FCFBLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 0.31 indicates that BLMN may have some problems paying its short term obligations.
  • With a Current ratio value of 0.31, BLMN is not doing good in the industry: 91.27% of the companies in the same industry are doing better.
  • BLMN has a Quick Ratio of 0.31. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of BLMN (0.24) is worse than 92.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.24
BLMN Yearly Current Assets VS Current LiabilitesBLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

3

3. BLMN Growth Analysis

3.1 Past

  • The earnings per share for BLMN have decreased strongly by -36.67% in the last year.
  • Measured over the past years, BLMN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -23.13% on average per year.
  • The Revenue has been growing slightly by 0.14% in the past year.
  • BLMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.53% yearly.
EPS 1Y (TTM)-36.67%
EPS 3Y-23.13%
EPS 5YN/A
EPS Q2Q%-34.21%
Revenue 1Y (TTM)0.14%
Revenue growth 3Y-3.6%
Revenue growth 5Y4.53%
Sales Q2Q%-11.09%

3.2 Future

  • BLMN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.57% yearly.
  • The Revenue is expected to grow by 1.59% on average over the next years.
EPS Next Y-22.96%
EPS Next 2Y-6.6%
EPS Next 3Y0.57%
EPS Next 5YN/A
Revenue Next Year0.02%
Revenue Next 2Y0.91%
Revenue Next 3Y1.59%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLMN Yearly Revenue VS EstimatesBLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
BLMN Yearly EPS VS EstimatesBLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2

7

4. BLMN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 5.27, which indicates a rather cheap valuation of BLMN.
  • BLMN's Price/Earnings ratio is rather cheap when compared to the industry. BLMN is cheaper than 97.62% of the companies in the same industry.
  • BLMN is valuated cheaply when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 6.84 indicates a rather cheap valuation of BLMN.
  • 95.24% of the companies in the same industry are more expensive than BLMN, based on the Price/Forward Earnings ratio.
  • BLMN is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.27
Fwd PE 6.84
BLMN Price Earnings VS Forward Price EarningsBLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BLMN is valued cheaper than 94.44% of the companies in the same industry.
  • BLMN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BLMN is cheaper than 97.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.29
EV/EBITDA 4.35
BLMN Per share dataBLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.6%
EPS Next 3Y0.57%

6

5. BLMN Dividend Analysis

5.1 Amount

  • BLMN has a Yearly Dividend Yield of 4.89%, which is a nice return.
  • BLMN's Dividend Yield is rather good when compared to the industry average which is at 1.05. BLMN pays more dividend than 96.83% of the companies in the same industry.
  • BLMN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.89%

5.2 History

  • The dividend of BLMN is nicely growing with an annual growth rate of 17.58%!
  • BLMN has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)17.58%
Div Incr Years0
Div Non Decr Years0
BLMN Yearly Dividends per shareBLMN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • BLMN pays out 464.56% of its income as dividend. This is not a sustainable payout ratio.
  • BLMN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP464.56%
EPS Next 2Y-6.6%
EPS Next 3Y0.57%
BLMN Yearly Income VS Free CF VS DividendBLMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M
BLMN Dividend Payout.BLMN Dividend Payout, showing the Payout Ratio.BLMN Dividend Payout.PayoutRetained Earnings

BLMN Fundamentals: All Metrics, Ratios and Statistics

BLOOMIN' BRANDS INC

NASDAQ:BLMN (4/29/2026, 5:32:43 PM)

After market: 6.01 0 (0%)

6.01

-0.02 (-0.33%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Industry Strength28.57
Industry Growth42.86
Earnings (Last)02-25
Earnings (Next)05-06
Inst Owners102.89%
Inst Owner Change-0.87%
Ins Owners0.9%
Ins Owner Change13.63%
Market Cap512.29M
Revenue(TTM)3.96B
Net Income(TTM)8.24M
Analysts69
Price Target7.61 (26.62%)
Short Float %8.42%
Short Ratio2.39
Dividend
Industry RankSector Rank
Dividend Yield 4.89%
Yearly Dividend0.45
Dividend Growth(5Y)17.58%
DP464.56%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)37.66%
Min EPS beat(2)-0.37%
Max EPS beat(2)75.69%
EPS beat(4)3
Avg EPS beat(4)23.2%
Min EPS beat(4)-0.37%
Max EPS beat(4)75.69%
EPS beat(8)5
Avg EPS beat(8)9.37%
EPS beat(12)9
Avg EPS beat(12)8.91%
EPS beat(16)13
Avg EPS beat(16)7.95%
Revenue beat(2)1
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)0.41%
Revenue beat(4)1
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.28%
Revenue beat(12)2
Avg Revenue beat(12)-1.39%
Revenue beat(16)3
Avg Revenue beat(16)-1.47%
PT rev (1m)-0.28%
PT rev (3m)-2.8%
EPS NQ rev (1m)-0.12%
EPS NQ rev (3m)-4.36%
EPS NY rev (1m)1.05%
EPS NY rev (3m)-6.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.39%
Valuation
Industry RankSector Rank
PE 5.27
Fwd PE 6.84
P/S 0.13
P/FCF 5.29
P/OCF 1.85
P/B 1.54
P/tB N/A
EV/EBITDA 4.35
EPS(TTM)1.14
EY18.97%
EPS(NY)0.88
Fwd EY14.61%
FCF(TTM)1.14
FCFY18.89%
OCF(TTM)3.25
OCFY54.01%
SpS46.41
BVpS3.91
TBVpS-3.51
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.0193 (66.71%)
Profitability
Industry RankSector Rank
ROA 0.26%
ROE 2.47%
ROCE 4.82%
ROIC 3.81%
ROICexc 3.91%
ROICexgc 5.45%
OM 2.79%
PM (TTM) 0.21%
GM 70.24%
FCFM 2.45%
ROA(3y)1.23%
ROA(5y)2.66%
ROE(3y)-10.51%
ROE(5y)21.12%
ROIC(3y)6.97%
ROIC(5y)9.18%
ROICexc(3y)7.23%
ROICexc(5y)9.53%
ROICexgc(3y)10.36%
ROICexgc(5y)14%
ROCE(3y)8.82%
ROCE(5y)11.62%
ROICexgc growth 3Y-32.33%
ROICexgc growth 5YN/A
ROICexc growth 3Y-30.79%
ROICexc growth 5YN/A
OM growth 3Y-28.44%
OM growth 5YN/A
PM growth 3Y-55.15%
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y0.25%
F-Score7
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 2.38
Debt/FCF 8.25
Debt/EBITDA 2.76
Cap/Depr 101.26%
Cap/Sales 4.55%
Interest Coverage 1.89
Cash Conversion 96.02%
Profit Quality 1174.82%
Current Ratio 0.31
Quick Ratio 0.24
Altman-Z 0.84
F-Score7
WACC7.77%
ROIC/WACC0.49
Cap/Depr(3y)132.2%
Cap/Depr(5y)120.26%
Cap/Sales(3y)5.97%
Cap/Sales(5y)5.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.67%
EPS 3Y-23.13%
EPS 5YN/A
EPS Q2Q%-34.21%
EPS Next Y-22.96%
EPS Next 2Y-6.6%
EPS Next 3Y0.57%
EPS Next 5YN/A
Revenue 1Y (TTM)0.14%
Revenue growth 3Y-3.6%
Revenue growth 5Y4.53%
Sales Q2Q%-11.09%
Revenue Next Year0.02%
Revenue Next 2Y0.91%
Revenue Next 3Y1.59%
Revenue Next 5YN/A
EBIT growth 1Y-46.08%
EBIT growth 3Y-31.02%
EBIT growth 5YN/A
EBIT Next Year109.66%
EBIT Next 3Y33.67%
EBIT Next 5YN/A
FCF growth 1Y1208.59%
FCF growth 3Y-17.32%
FCF growth 5Y13.67%
OCF growth 1Y21.29%
OCF growth 3Y-10.88%
OCF growth 5Y14.79%

BLOOMIN' BRANDS INC / BLMN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BLOOMIN' BRANDS INC (BLMN) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BLMN.


Can you provide the valuation status for BLOOMIN' BRANDS INC?

ChartMill assigns a valuation rating of 7 / 10 to BLOOMIN' BRANDS INC (BLMN). This can be considered as Undervalued.


Can you provide the profitability details for BLOOMIN' BRANDS INC?

BLOOMIN' BRANDS INC (BLMN) has a profitability rating of 3 / 10.


What is the valuation of BLOOMIN' BRANDS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BLOOMIN' BRANDS INC (BLMN) is 5.27 and the Price/Book (PB) ratio is 1.54.


What is the financial health of BLOOMIN' BRANDS INC (BLMN) stock?

The financial health rating of BLOOMIN' BRANDS INC (BLMN) is 2 / 10.